Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.

Biotechnology

Charles River Laboratories

James C. Foster

Dan Small

Lucy Podbielski

Flavia Pease

Kerstin Dolph

Bruce Haynes

Mark Mintz

William D. Barbo

Vicky Creamer

Shannon M. Parisotto

Matthew L. Daniel

Glenn Washer

Gina Mullane

Geoffrey C. Goldsmith

Birgit Girshick

David P. Johst

John C. Ho

Brian Bathgate

W. Laplume

Michael G. Knell

Kristen M. Eisenhauer

Colin Dunn

The Leadership Team at Charles River Laboratories is responsible for setting the strategic direction and operational priorities of the company across its various segments, including Research Models and Services, Discovery and Safety Assessment, and Manufacturing Support. This team, composed of senior executives, collaborates to enhance service delivery, ensure legal compliance, drive innovation, and optimize global operations, ultimately supporting the company’s mission to advance clinical research and development for its clients.

Leadership Team

Business Development and Sales

Leadership Team

About

Team members

Other teams at Charles River Laboratories

Business Development and Sales